Clinical Trials in Detroit

Showing 18021-18040 of 19,719 trials

Readiness for Behavior Change After a Heart Attack

NCT01596036

The purpose of this study is to test if an early appointment (within 10 days) when compared to a standard appointment (5 weeks) will affect attendance at the Cardiac Rehabilitation orientation and subsequent enrollment into cardiac rehabilitation.

Myocardial InfarctionStable AnginaCoronary Artery Disease

Henry Ford Health System150 participantsStarted Feb 2011

Detroit, Michigan, United States

COMPLETEDPhase 36.7 miles

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

NCT00307047

The purpose of the SPIRIT IV Clinical Trial is to continue to evaluate the safety and efficacy of the XIENCE V® Everolimus Eluting Coronary Stent System (XIENCE V®). The XIENCE V® arm will be compared to an active control, represented by the FDA-approved TAXUS® EXPRESS2™ Paclitaxel-Eluting Coronary Stent System (TAXUS®), commercially available from Boston Scientific. TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent System is manufactured by Boston Scientific.

Coronary Artery Disease

Abbott Medical Devices3,687 participantsStarted Aug 2006

Scottsdale, Arizona, United States • Little Rock, Arkansas, United States • Fairfax, California, United States +62 more locations

Readiness for Behavior Change After a Heart Attack

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Find Trials by Condition in Detroit

An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants

Study of Efficacy of Ramelteon in Adults With Chronic Insomnia

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)

Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans

Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation

A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine

Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer

A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects